Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-02-14 6:31 pm Sale | 2024-12-31 | 13G | Day One Biopharmaceuticals, Inc. DAWN | RA Capital Management, L.P. | 5,755,577 5.700% | -2,054,275 (-26.30%) | Filing History |
| 2025-02-12 09:28 am Purchase | 2024-12-31 | 13G | Day One Biopharmaceuticals, Inc. DAWN | FMR LLC | 12,887,467 12.800% | 1,600,140 (+14.18%) | Filing History |
| 2024-11-14 4:30 pm Sale | 2024-09-30 | 13G | Day One Biopharmaceuticals, Inc. DAWN | Atlas Venture Fund XI, L.P. | 4,869,681 5.500% | -1,178,137 (-19.48%) | Filing History |
| 2024-11-07 09:24 am Purchase | 2024-11-06 | 13G | Day One Biopharmaceuticals, Inc. DAWN | FMR LLC | 11,287,327 11.192% | 3,874,947 (+52.28%) | Filing History |
| 2024-11-07 09:12 am Purchase | 2024-11-06 | 13G | Day One Biopharmaceuticals, Inc. DAWN | FMR LLC | 7,412,380 7.539% | 3,444,214 (+86.80%) | Filing History |
| 2024-08-05 5:05 pm Unchanged | 2024-08-01 | 13D | Day One Biopharmaceuticals, Inc. DAWN | AI Day1 LLC | 12,929,322 13.150% | 0 (Unchanged) | Filing History |
| 2024-02-14 5:01 pm Purchase | 2023-12-31 | 13G | Day One Biopharmaceuticals, Inc. DAWN | RA Capital Management, L.P. | 7,809,852 9.000% | 769,230 (+10.93%) | Filing History |
| 2024-02-13 5:02 pm Purchase | 2023-12-29 | 13G | Day One Biopharmaceuticals, Inc. DAWN | The Vanguard Group | 4,769,746 5.480% | 4,769,746 (New Position) | Filing History |
| 2024-02-09 4:08 pm Purchase | 2023-12-31 | 13G | Day One Biopharmaceuticals, Inc. DAWN | Atlas Venture Fund XI, L.P. | 6,047,818 6.900% | 39,284 (+0.65%) | Filing History |
| 2024-02-09 08:50 am Sale | 2024-02-08 | 13G | Day One Biopharmaceuticals, Inc. DAWN | FMR LLC | 3,968,166 4.558% | -2,050,892 (-34.07%) | Filing History |
| 2024-01-29 5:25 pm Purchase | 2023-12-31 | 13G | Day One Biopharmaceuticals, Inc. DAWN | BlackRock Inc. BLK | 5,126,071 5.900% | 5,126,071 (New Position) | Filing History |
| 2023-10-20 4:01 pm Purchase | 2023-10-18 | 13D | Day One Biopharmaceuticals, Inc. DAWN | AI Day1 LLC | 12,929,322 14.870% | 1,475,454 (+12.88%) | Filing History |
| 2023-08-10 08:19 am Sale | 2023-08-09 | 13G | Day One Biopharmaceuticals, Inc. DAWN | FMR LLC | 6,019,058 6.931% | -2,983,252 (-33.14%) | Filing History |
| 2023-06-12 4:12 pm Purchase | 2023-06-09 | 13D | Day One Biopharmaceuticals, Inc. DAWN | AI Day1 LLC | 11,453,868 13.190% | 769,230 (+7.20%) | Filing History |
| 2023-02-14 4:45 pm Purchase | 2022-12-31 | 13G | Day One Biopharmaceuticals, Inc. DAWN | RA Capital Management, L.P. | 7,040,622 9.600% | 2,075,034 (+41.79%) | Filing History |
| 2023-02-14 4:23 pm Sale | 2022-12-31 | 13G | Day One Biopharmaceuticals, Inc. DAWN | Atlas Venture Fund XI, L.P. | 6,008,534 8.200% | -1,201,708 (-16.67%) | Filing History |
| 2023-02-09 09:59 am Purchase | 2023-02-09 | 13G | Day One Biopharmaceuticals, Inc. DAWN | FMR LLC | 9,002,310 12.239% | 693,136 (+8.34%) | Filing History |
| 2023-02-03 5:06 pm Sale | 2022-06-21 | 13G | Day One Biopharmaceuticals, Inc. DAWN | TAKEDA PHARMACEUTICAL CO LTD | 0 0.000% | -6,012,758 (Position Closed) | Filing History |
| 2022-11-02 4:15 pm Sale | 2022-10-31 | 13D | Day One Biopharmaceuticals, Inc. DAWN | Canaan XI L.P. | 2,548,403 3.500% | -2,200,000 (-46.33%) | Filing History |
| 2022-10-19 5:29 pm Sale | 2022-10-17 | 13D | Day One Biopharmaceuticals, Inc. DAWN | Canaan XI L.P. | 4,748,403 6.500% | -2,215,898 (-31.82%) | Filing History |